Avenue Therapeutics Inc. buy BiotechBee
Start price
22.07.24
/
50%
€3.28
Target price
30.06.26
€5.00
Performance (%)
-46.65%
End price
14.12.24
€1.75
Summary
This prediction ended on 14.12.24 with a price of €1.75. The BUY prediction by BiotechBee for Avenue Therapeutics Inc. performed very badly with a performance of -46.65%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
According to BiotechBee what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Avenue Therapeutics Inc.
Buy beendet

